IL101708A - Anti-fattening drugs comprising amino acid derivatives - Google Patents

Anti-fattening drugs comprising amino acid derivatives

Info

Publication number
IL101708A
IL101708A IL10170892A IL10170892A IL101708A IL 101708 A IL101708 A IL 101708A IL 10170892 A IL10170892 A IL 10170892A IL 10170892 A IL10170892 A IL 10170892A IL 101708 A IL101708 A IL 101708A
Authority
IL
Israel
Prior art keywords
fattening
formula
drugs
group
amino acid
Prior art date
Application number
IL10170892A
Other languages
English (en)
Other versions
IL101708A0 (en
Original Assignee
Senyorina Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senyorina Ltd filed Critical Senyorina Ltd
Priority to IL10170892A priority Critical patent/IL101708A/en
Publication of IL101708A0 publication Critical patent/IL101708A0/xx
Priority to AT93909847T priority patent/ATE150967T1/de
Priority to JP51890793A priority patent/JP3666667B2/ja
Priority to DK93909847.1T priority patent/DK0637958T3/da
Priority to CA002134560A priority patent/CA2134560C/fr
Priority to AU40626/93A priority patent/AU4062693A/en
Priority to EP93909847A priority patent/EP0637958B1/fr
Priority to DE69309457T priority patent/DE69309457T2/de
Priority to PCT/EP1993/001014 priority patent/WO1993021913A1/fr
Priority to US08/616,948 priority patent/US5602164A/en
Publication of IL101708A publication Critical patent/IL101708A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL10170892A 1992-04-28 1992-04-28 Anti-fattening drugs comprising amino acid derivatives IL101708A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IL10170892A IL101708A (en) 1992-04-28 1992-04-28 Anti-fattening drugs comprising amino acid derivatives
PCT/EP1993/001014 WO1993021913A1 (fr) 1992-04-28 1993-04-27 Medicaments contre l'obesite
CA002134560A CA2134560C (fr) 1992-04-28 1993-04-27 Medicaments contre l'obesite
JP51890793A JP3666667B2 (ja) 1992-04-28 1993-04-27 抗−肥満薬
DK93909847.1T DK0637958T3 (da) 1992-04-28 1993-04-27 Anti-fedme medikamenter
AT93909847T ATE150967T1 (de) 1992-04-28 1993-04-27 Wirkstoffe gegen fettleibigkeit
AU40626/93A AU4062693A (en) 1992-04-28 1993-04-27 Anti-obesity drugs
EP93909847A EP0637958B1 (fr) 1992-04-28 1993-04-27 Medicaments contre l'obesite
DE69309457T DE69309457T2 (de) 1992-04-28 1993-04-27 Wirkstoffe gegen fettleibigkeit
US08/616,948 US5602164A (en) 1992-04-28 1996-03-18 Anti-obesity drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10170892A IL101708A (en) 1992-04-28 1992-04-28 Anti-fattening drugs comprising amino acid derivatives

Publications (2)

Publication Number Publication Date
IL101708A0 IL101708A0 (en) 1992-12-30
IL101708A true IL101708A (en) 1996-08-04

Family

ID=11063576

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10170892A IL101708A (en) 1992-04-28 1992-04-28 Anti-fattening drugs comprising amino acid derivatives

Country Status (9)

Country Link
EP (1) EP0637958B1 (fr)
JP (1) JP3666667B2 (fr)
AT (1) ATE150967T1 (fr)
AU (1) AU4062693A (fr)
CA (1) CA2134560C (fr)
DE (1) DE69309457T2 (fr)
DK (1) DK0637958T3 (fr)
IL (1) IL101708A (fr)
WO (1) WO1993021913A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271267B (it) * 1994-12-14 1997-05-27 Valle Francesco Della Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
DE60117472T2 (de) * 2001-11-26 2006-09-28 Lean-Ex Ltd., Pharmazeutische zusammensetzung zur behandlung von fettleibigkeit
US20060057220A1 (en) * 2002-10-07 2006-03-16 Yoko Matsuzawa Fine spherical particles with satisfactory molecular orientation, spherical microcapsules comprising the same and processes for producing these
ITMI20041567A1 (it) * 2004-07-30 2004-10-30 Maycos Italiana Di Comini Miro "derivati n-acilati di acidi bicarbossilici con amminoacidi e con idrolizzati proteici vegetali e loro applicazione in prodotti cosmetici, dermofarmaceutici e farmaceutici"
WO2007013062A1 (fr) * 2005-07-25 2007-02-01 Lean-Ex Ltd. Composition et procede de stabilisation du poids
CN104649926B (zh) * 2013-11-25 2018-08-17 刘现梅 一种n,n’-癸二酰基二天门冬氨酸及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234399A1 (de) * 1972-07-17 1974-01-31 Thomae Gmbh Dr K Hautschutzmittel
DE3423166A1 (de) * 1984-06-22 1986-01-02 Epis S.A., Zug Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
EP0637958B1 (fr) 1997-04-02
CA2134560C (fr) 2002-03-19
JPH07508719A (ja) 1995-09-28
ATE150967T1 (de) 1997-04-15
WO1993021913A1 (fr) 1993-11-11
AU4062693A (en) 1993-11-29
CA2134560A1 (fr) 1993-11-11
DE69309457T2 (de) 1997-11-06
IL101708A0 (en) 1992-12-30
EP0637958A1 (fr) 1995-02-15
JP3666667B2 (ja) 2005-06-29
DE69309457D1 (de) 1997-05-07
DK0637958T3 (da) 1997-10-13

Similar Documents

Publication Publication Date Title
EP1014965B1 (fr) Compositions dietetiques servant a ameliorer le metabolisme et attenuer les agressions oxydatives
AU664511B2 (en) Method of promoting nitrogen retention in humans
US4268524A (en) Method of treating abnormal lipoprotein ratios with acylcarnitine
ITRM950824A1 (it) Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
JP2009242413A (ja) アミノ酸をベースとする医薬
Hänni Pharmacokinetic and metabolic pathways of systemically applied retinoids
WO2008069652A1 (fr) Combinaisons d'un sphingolipide et d'un inhibiteur de la hmg-coa réductase pour le traitement de l'hypercholestérolémie
US5420335A (en) Parenteral nutrients based on watersoluble glycerol bisacetoacetates
EP0637958B1 (fr) Medicaments contre l'obesite
AU679818B2 (en) Butyric ester cyto-differentiating agents
US5602164A (en) Anti-obesity drugs
CA2134380C (fr) Composition a base d'acides amines servant au traitement de la septicemie ou d'une atteinte induisant une reaction inflammatoire
US4997852A (en) Method and composition for achieving cancer chemopreventive and chemotherapeutic activity
JPH04312527A (ja) 肝不全および肝臓疾患の治療方法
CN101652134A (zh) 用于预防和/或治疗脂肪肝或非酒精性脂肪性肝炎的药物
US20130296390A1 (en) Method and compositions for enhancing the safety of orally administered magnesium alpha-lipoate
CA2493398A1 (fr) Preparation de complement nutritionnel et alimentaire comprenant des analogues, derives et complexes de la creatine et de l'acide orotique
AU2007358961A1 (en) Composition and method for increasing the anabolic state of muscle cells
CA2598786C (fr) Composition et procede d'augmentation de l'anabolisme des cellules musculaires
US7645794B2 (en) Composition and method for increasing the anabolic state of muscle cells
ITRM980445A1 (it) Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
EP0003353A1 (fr) Composition pharmaceutique pour administration par voie orale pour le traitement de l'hypertension
CN1482902A (zh) TNFα生成抑制剂
JPH07206684A (ja) 肝障害抑制剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
KB Patent renewed